PATENT - The Salt Lake Tribune http://www.sltrib.com/feeds/topics/PATENT News from The Salt Lake Tribune en-us webmaster@sltrib.com (Webmaster) Comcast wins $7.5M in patent trial with Sprint http://www.sltrib.com/sltrib/money/58526262-79/sprint-comcast-trial-infringement.html.csp <div class="hnews hentry item"> <h4><a class="url entry-title" href="http://www.sltrib.com/sltrib/money/58526262-79/sprint-comcast-trial-infringement.html.csp">Comcast wins $7.5M in patent trial with Sprint</a></h4> <span class="author vcard"><span class="fn">By Phil Milford</span></span> <span class="source-org vcard"><span class="org fn"> Bloomberg News</span></span> <h5><span class="updated" title="2014-10-15T16:52:02.065-06:00">Updated Oct 15, 2014 04:52PM MDT</span></h5> <div class ="entry-content">Wilmington, Del. • Comcast Corp., the largest U.S. cable company, has won $7.5 million in damages from wireless carrier Sprint Corp. for infringing telecommunications patents after a four-day federal jury trial. Comcast had asked for $16.5 million. Comcast, which is seeking regulatory approval to buy rival Time Warner Cable Inc. for $45.2 billion, sued Overland Park, Kan.-based Sprint in 2012 in Wilmington, alleging Sprint used its protected technology for methods of call-routing over the Intern...</div> <h5><a rel="item-license" href="http://www.sltrib.com/pages/privacy"> Copyright 2013 The Salt Lake Tribune. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.</a></h5> </div> 58526262@www.sltrib.com Wed, 15 Oct 2014 16:52:02 MDT Supreme Court weighs generic drug dispute http://www.sltrib.com/sltrib/money/58524589-79/court-patent-drug-teva.html.csp <div class="hnews hentry item"> <h4><a class="url entry-title" href="http://www.sltrib.com/sltrib/money/58524589-79/court-patent-drug-teva.html.csp">Supreme Court weighs generic drug dispute</a></h4> <span class="author vcard"><span class="fn">By SAM HANANEL</span></span> <span class="source-org vcard"><span class="org fn"> The Associated Press</span></span> <h5><span class="updated" title="2014-10-15T11:56:03.264-06:00">Updated Oct 15, 2014 11:56AM MDT</span></h5> <div class ="entry-content">Washington • The Supreme Court seems divided as it considers a high-stakes patent dispute between rival pharmaceutical companies over the world’s best-selling multiple sclerosis treatment. Justices heard arguments Wednesday in a case that threatens to cut into the profits of Israel-based Teva Pharmaceutical Industries Ltd., which sells $4 billion annually of the drug Copaxone. Teva claims the U.S. Court of Appeals for the Federal Circuit wrongly overturned five of its patents for the drug. That ...</div> <h5><a rel="item-license" href="#license-585245892014-10-15T11:56:03.264-06:00" id="#license-2014-10-15T11:56:03.264-06:00"> Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.</a></h5> </div> 58524589@www.sltrib.com Wed, 15 Oct 2014 11:56:03 MDT